March 03, 2025

More States Fast Track Foreign-Trained Physicians

Since 2023, nine states have waived U.S. residency requirements for some foreign-trained physicians, with more states considering similar changes.

KFF Health News

February 26, 2025

New Medical Malpractice Rules Issued by American Law Institute

The American Law Institute's first restatement of medical malpractice law shifts focus from customary practice to evidence-based medicine.

Conexiant

February 25, 2025

Study Links Genetic Variants to Smoking Cessation

A large genome-wide study identified genetic variants linked to varenicline-aided smoking cessation, revealing roles in metabolism, neural pathways, and addiction response.

Conexiant

February 24, 2025

New Sublocade Label Allows for Faster Treatment Initiation

The FDA has approved updated labeling for buprenorphine extended-release (Sublocade), introducing a rapid initiation protocol and expanded injection sites to enhance treatment flexibility for opioid use disorder.

Conexiant

February 24, 2025

Do Black Female Doctors Die Earlier?

New JAMA Internal Medicine study finds Black female physicians face higher mortality rates than White women in general population.

Conexiant

February 20, 2025

Medical Oddities: Sugar Sensors in the Heart?

Sugar sensors are found in the heart. Tea ingredient turned into hydrogel. Mind-reading is getting closer. And more.

Conexiant

February 20, 2025

Smoking Cessation Intervention Effective in Opioid Users

Providing nicotine replacement and behavioral support at opioid agonist therapy clinics helped patients halve their cigarette consumption, study finds.

Conexiant

February 20, 2025

NY Sues Major Vape Distributors Over Youth Marketing

Attorney General Letitia James files lawsuit against 13 e-cigarette companies for allegedly targeting minors with flavored nicotine products, seeking hundreds of millions in damages and penalties.

Conexiant

February 18, 2025

FDA Qualifies Two-Level RDL for AUD Trials

The drug development tool offers an alternative, clinically meaningful endpoint in clinical trials that evaluate pharmacologic treatments for alcohol use disorder.

Conexiant